Talking as a Drug — Administering LLM Conversations for Medical Treatment in Elder Care
Conversational agents are increasingly proposed as companions for older adults. This interdisciplinary position paper asks what changes if we describe such conversations the way medicine describes a treatment: with a dosage, an expected effect, side effects, contraindications and a requirement of informed consent — and who carries responsibility when the treatment is a model.
Citation
T. Hallyburton and R. E. Martín-Peña. "Talking as a Drug — Administering LLM Conversations for Medical Treatment in Elder Care." CEUR Workshop Proceedings, Bremen, Germany, 2026. Presented at ETHICAIA/IJCAI 2026.
